Elsevier

Cytokine

Volume 46, Issue 2, May 2009, Pages 236-244
Cytokine

Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies

https://doi.org/10.1016/j.cyto.2009.02.003Get rights and content

Abstract

The role of inflammation is being considered in chronic diseases. Previous studies have examined SNPs in a few key inflammatory genes and have included small numbers of African American participants. Variation in the frequencies of inflammatory pathway SNPs may help to explain racial disparities in disease risk. Through a population-based study of 103 African American and 380 Caucasian unrelated, healthy women, we examined the relationships between race and allele frequencies of 70 cytokine and cytokine receptor SNPs. The associations between genotypic and haplotype frequencies and race were also analyzed. Allelic frequencies for 52 out of the 70 SNPs meeting criteria for analysis differed significantly by race. Of the 32 pro-inflammatory and 20 anti-inflammatory SNPs for which the allele frequencies varied significantly by race, variant allele frequency differences between Caucasians and African Americans ranged between 6–37% and 7–53% for pro-inflammatory SNPs and anti-inflammatory SNPs, respectively. Our findings suggest that while allele frequencies do vary by race, racial groups are not simplistically represented by a pro-inflammatory or anti-inflammatory genetic profile. Given the racial variability in allele frequencies in inflammatory gene SNPs, studies examining the association between these SNPs and disease should at least incorporate self-reported race in their analyses.

Introduction

Differences by race in incidence for diseases associated with inflammation suggest that there may be underlying racial differences in inflammatory pathway genes. For example, there is racial variation in the incidence of several autoimmune diseases such as systemic lupus erythematosus (SLE) and multiple sclerosis (MS), and infectious diseases such as tuberculosis, septicemia, and HIV/AIDs [1]. The incidence of several types of cancer associated with inflammation and/or chronic infection, including colorectal, liver and bile, lung and bronchus, prostate, and stomach, is also elevated in African Americans relative to Caucasians, especially among men [2]. Finally, several markers of inflammation, including C-reactive protein and homocysteine, have been shown to be associated with cardiovascular disease and to be elevated in African Americans [3].

One set of markers of inflammatory pathways are cytokines and cytokine receptors. Differences in protein expression of IL-6 SR between healthy, older African Americans and Caucasians have been shown in at least one study [4]. While few studies have examined the relationship between cytokine protein expression and race, studies investigating the association between cytokine single nucleotide polymorphisms (SNPs) and race have been previously published [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18]. These studies have focused on SNPs in only a few cytokines including tumor necrosis factor (TNF), IL1A, IL1B, IL6, IL2, IFNG, IL18, and IL10.

The consensus from these published reports is that among African Americans there is an increase in the frequency of alleles associated with high production of pro-inflammatory T helper type I (TH1) cytokines and low production of anti-inflammatory T helper type II (TH2) cytokines. These results suggest the potential for systemic inflammatory upregulation in African Americans. Specifically, IL1A −889T, IL1B −3957C and −511A, IL6 −174G, IL18 −137G, TNFA −308A, and IFNG −874 alleles are associated with an increase in cytokine production and are found more frequently among African Americans [7], [9], [11], [13]. IL10 −592A, −819T, and −1082A alleles, associated with decreased IL-10 production, are also found more frequently among African Americans [7], [9], [13], [15]. In contrast, another study reported that the pro-inflammatory IL2 −330G allele, associated with increased IL-2 production, was found less frequently among African Americans than among Caucasians [9]. Furthermore, some studies have found no relationship between allele frequency of the TNFA −308 polymorphism and race [7], [9], [11].

To expand this research, we examined the association between race and 70 cytokine and cytokine receptor polymorphisms in 26 inflammation-related genes among African American and Caucasian women in a large, population-based study.

Section snippets

Study participants

Subjects were population-based healthy controls obtained through a study comparing controls frequency matched on age and self-reported race to women with non-small cell lung cancer (NSCLC) [19]. Control participants were women without a history of NSCLC between the ages of 18 and 74 living in the Detroit metropolitan area and were identified through random-digit dialing. Of the households that completed the eligibility screening questionnaire, 69.6% (N = 575) participated in the interview. 209

Sample

Our sample included 103 population-based African American women (21.3%) and 380 Caucasian (78.7%) women.

Cytokine and cytokine receptor SNPs

Five (IL3-rs40401; IL12B-rs730690; TNF-rs3093661; IL10RA-rs9610; TGFB1-rs1800471) and two (IL8RB-rs1126579; IFNGR1-rs11914) out of 83 cytokine and cytokine receptor SNPs on the cancer SNP panel were not in Hardy–Weinberg equilibrium for African Americans and Caucasians, respectively. For an additional six SNPs (IL8-rs2227549; IL8RB-rs1126579; IFNGR1-rs3799488; TNF-rs3093661; LTA-rs3093546,

Discussion

We observed allelic frequency differences by race for 52 of the 70 SNPs meeting criteria for analysis. General genotypic frequency differences between African Americans and Caucasians were observed for 49 of these 52 SNPs. Significant trends in genotypic frequency by race were found for all of these 52 SNPs. While the same haplotypes were constructed for African Americans and Caucasians for all genes for which multiple SNPs were analyzed, there was marked variation in haplotype frequency by

Conclusions

We found that cytokine and cytokine receptor SNP allelic, genotypic and haplotype frequencies varied significantly by race. These results suggest that future analyses of the associations between cytokine and cytokine receptor SNPs and disease risk and prognosis should at least consider self-reported race, if not more complex measures such as race and socioeconomic status or genetic ancestry. Additionally, the conclusion by Ness et al. [13] that African Americans have an increased allele

Conflict of interest

None.

References (36)

  • M.A. Albert

    Inflammatory biomarkers, race/ethnicity and cardiovascular disease

    Nutrition Rev

    (2007)
  • M. Osiri et al.

    A novel single nucleotide polymorphism and five probable haplotypes in the 5’ flanking region of the IL-6 gene in African-Americans

    Genes Immun

    (1999)
  • M.P. Reynard et al.

    Allele frequencies of polymorphism of the tumor necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 genes in a Norther European Caucasoid group from the UK

    Eur J Immunogen

    (2000)
  • E.D. Cox et al.

    Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6

    Transplantation

    (2001)
  • S.C. Hoffman et al.

    Ethnicity greatly influences cytokine gene polymorphism distribution

    Am J Transplant

    (2002)
  • S.L. Bridges et al.

    Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences

    Arthritis Rheum

    (2002)
  • R.B. Ness et al.

    Differential distribution of allelic variants in cytokine genes among African Americans and white Americans

    Am J Epid

    (2004)
  • D.P. Nguyen et al.

    Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women

    Obstet Gyn

    (2004)
  • Cited by (0)

    This research was funded by NIH Grant R01-CA87895 and Contracts N01-PC35145 and P30CA22453.

    View full text